Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The present study was conceived to evaluate the effects of levosimendan on cardiopulmonary
exercise test (CPET) and DLCO ( Diffusion capacity of Lung for carbon monoxide) in patients
with severe heart failure in stable clinical conditions (NYHA - New York Heart Association -
class III, with a peak VO2 (Oxygen consumption ) < 12 ml/min/kg) on top of optimized standard
therapy.